Expert Gallbladder & Biliary Care

• Gallstones (cholelithiasis): hardened deposits of bile or cholesterol in the gallbladder
• Biliary sludge: a collection of microscopic cholesterol and bile particles
• Cholecystitis: inflammation of the gallbladder, often caused by gallstones
• Adenomyomatosis: a non-cancerous thickening of the gallbladder wall
• Gallbladder polyps: small, benign growths in the gallbladder lining
• Functional gallbladder disorder (biliary dyskinesia): abnormal gallbladder function without stones

Causes vary depending on the condition:

• Gallstones and biliary sludge: imbalance in bile composition, genetics, obesity or rapid weight loss
• Cholecystitis: blockage of the cystic duct, usually by gallstones
• Adenomyomatosis and polyps: the exact causes are unclear but may be linked to chronic inflammation
• Functional disorders: thought to result from abnormal gallbladder motility or hypersensitivity

• Persistent pain in the upper right abdomen, especially after meals (biliary colic)
• Nausea or vomiting
• Indigestion, bloating or fatty food intolerance
• Fever and chills, which may indicate inflammation or infection
• Yellowing of the skin or eyes (jaundice), which could indicate bile duct obstruction

• Medical history and physical examination to identify symptoms
• Ultrasound imaging to detect gallstones, polyps or thickened walls
• HIDA scan (cholescintigraphy): evaluates gallbladder function
• CT or MRI scans for complex cases
• Blood tests to assess liver function and rule out infection or obstruction

• Lifestyle changes: a low-fat diet to reduce symptoms in mild cases
• Medications: to dissolve small gallstones (rarely effective)
• Laparoscopic cholecystectomy (gallbladder removal): the most common treatment for symptomatic gallstones or cholecystitis
• Endoscopic procedures: to remove stones in the bile duct or address blockages
• Monitoring: for small, asymptomatic polyps or adenomyomatosis

Most benign gallbladder diseases, like gallstones or adenomyomatosis, rarely progress to cancer. However, chronic inflammation from untreated conditions may slightly increase the risk of gallbladder cancer. Regular follow-ups can help mitigate this risk.

Yes, most people live normal, healthy lives after gallbladder removal. The liver continues to produce bile for digestion, though fatty meals may require dietary adjustments initially.

• Maintain a healthy weight and avoid rapid weight loss
• Follow a balanced diet with moderate fat intake and plenty of fibre
• Stay physically active
• Drink plenty of water to aid digestion and bile production

Gallbladder cancer is a malignant tumour that begins in the gallbladder cells, a small organ beneath the liver that stores bile. The most common type is adenocarcinoma, which starts in the epithelial cells lining the gallbladder.

Gallbladder cancer is rare but more common in regions like India, Pakistan, South America and Eastern Europe. Women are affected more often than men, typically in their 60s or 70s.

The exact cause is unknown, but certain factors increase the risk:

• Gallstones: chronic inflammation due to gallstones is a significant risk factor
• Porcelain gallbladder: calcification of the gallbladder wall from long-term inflammation
• Chronic infections: recurrent infections in the bile ducts
• Gallbladder polyps: larger polyps (greater than 1 cm) carry a higher risk
• Obesity: increases the risk of gallstones and inflammation
• Family history: genetic predisposition in some cases
• Exposure to toxins: certain chemicals or industrial exposures

Early stages often have no symptoms. As the disease progresses, patients may experience:

• Abdominal pain, especially in the upper right side
• Nausea and vomiting
• Jaundice (yellowing of the skin and eyes)
• Weight loss and loss of appetite
• Fever and fatigue
• A lump in the abdomen

Imaging studies:

• Ultrasound: often the first test to detect abnormalities
• CT or MRI scans: provide detailed images of the gallbladder and surrounding areas
• PET scans: to identify cancer spread (metastasis)

Endoscopic procedures:

• ERCP: to evaluate bile ducts and collect samples
• Endoscopic ultrasound: for detailed imaging and biopsy

Blood tests: liver function tests to check for bile duct obstruction, and tumour markers like CA 19-9 or CEA, which may be elevated. A biopsy confirms the diagnosis by examining tissue under a microscope.

Gallbladder cancer is staged based on tumour size, spread and lymph node involvement:

• Stage 0: cancer is limited to the inner lining (in situ)
• Stage I: tumour is confined to the gallbladder wall
• Stage II: tumour has invaded nearby tissues but not lymph nodes
• Stage III: cancer involves lymph nodes or nearby organs
• Stage IV: advanced cancer with distant metastasis

Treatment depends on the stage and the patient's health.

Surgery:

• Cholecystectomy: removal of the gallbladder, used in early-stage cancer
• Extended surgery: includes removal of part of the liver and lymph nodes for advanced local disease

• Chemotherapy: used for advanced cancer to shrink tumours, or after surgery to reduce recurrence risk
• Radiation therapy: targets cancer cells, often combined with chemotherapy
• Palliative care: focused on symptom relief in advanced, inoperable cases

Gallbladder cancer is curable if detected early and surgically removed. Unfortunately, many cases are diagnosed at advanced stages, making treatment more challenging.

While prevention is not always possible, certain measures can reduce risk:

• Treat gallstones and chronic gallbladder inflammation promptly
• Maintain a healthy weight and diet
• Avoid smoking and exposure to industrial toxins

Prognosis depends on the stage at diagnosis:

• Early-stage cancers have a higher survival rate, especially after complete surgical removal
• Advanced stages are associated with poorer outcomes, but advances in treatment are improving survival and quality of life

Gallstones are solid particles that form in the gallbladder from bile components such as cholesterol, bile salts and bilirubin. They form due to an imbalance in bile composition, often made worse by:

• Obesity
• Rapid weight loss
• A high-fat, low-fibre diet
• Genetics

Gallstones are present in 80–90% of patients with gallbladder cancer, making it one of the most strongly associated risk factors. However, it is essential to note that only a tiny fraction of individuals with gallstones will develop gallbladder cancer.

Gallstones contribute to risk primarily through chronic inflammation:

• Irritation of the gallbladder wall: persistent presence of gallstones leads to repeated injury and inflammation of the lining
• Cellular damage: chronic inflammation causes changes in the DNA of gallbladder cells, increasing the risk of malignancy
• Porcelain gallbladder: prolonged inflammation may cause calcium deposits in the wall, a condition associated with higher cancer risk

Yes, both influence risk:

• Larger gallstones are associated with a higher risk of cancer
• Chronic gallstone disease: long-standing gallstones increase the risk due to prolonged inflammation and damage

• Women: gallbladder cancer is more common in women, partly due to their higher prevalence of gallstone disease
• Older adults: risk increases with age, particularly after 60
• Geographic and ethnic factors: higher rates are observed in South Asia, Latin America and Indigenous populations in North America
• Individuals with a family history: genetics play a role in both gallstone disease and gallbladder cancer

Gallstones often cause no symptoms. However, signs that may indicate complications or gallbladder cancer include:

• Persistent upper-right abdominal pain
• Unexplained weight loss
• Jaundice (yellowing of the skin and eyes)
• A palpable lump in the abdomen
• Fever or chills indicating infection

Yes. Cholecystectomy is the most effective way to eliminate the risk of gallbladder cancer in patients with symptomatic gallstones or high-risk conditions such as:

• Large gallstones
• Porcelain gallbladder
• Gallbladder polyps larger than 1 cm

For asymptomatic gallstones, surgery is usually not recommended unless other risk factors are present.

Early detection is challenging because gallbladder cancer symptoms overlap with benign gallstone disease. Methods include:

• Imaging tests: ultrasound, CT or MRI to detect abnormalities
• Endoscopic procedures: ERCP or endoscopic ultrasound for detailed evaluation and biopsy
• Tumour markers: blood tests like CA 19-9 and CEA may aid in detection, although they are not definitive

While not all cases can be prevented, you can reduce your risk by:

• Maintaining a healthy weight
• Eating a balanced diet rich in fibre and low in unhealthy fats
• Staying physically active
• Treating symptomatic gallstones promptly — avoid delaying surgery if advised by your doctor

If you have gallstones, stay vigilant about your symptoms and follow your doctor's recommendations. While the risk of gallbladder cancer is low, addressing gallstone-related complications early can prevent chronic inflammation and reduce cancer risk.

Benign biliary diseases are non-cancerous conditions affecting the bile ducts or gallbladder. Common examples include:

• Cholelithiasis (gallstones): stones formed in the gallbladder or bile ducts
• Cholangitis: inflammation of the bile ducts, often caused by infection or obstruction
• Choledocholithiasis: gallstones lodged in the common bile duct
• Biliary strictures: narrowing of the bile ducts, often due to injury or inflammation
• Biliary dyskinesia: dysfunctional bile duct or gallbladder motility
• Primary biliary cholangitis (PBC): chronic autoimmune disease causing bile duct damage

• Gallstones: result from bile composition imbalances, obesity or rapid weight loss
• Cholangitis: usually caused by bacterial infection following bile duct obstruction
• Strictures: may develop after surgery, injury or chronic inflammation
• Biliary dyskinesia: often idiopathic, but stress and hormonal changes may contribute
• Primary biliary cholangitis: an autoimmune reaction damaging the small bile ducts

Symptoms range from mild discomfort to severe pain:

• Right upper abdominal pain, especially after eating fatty foods
• Jaundice (yellowing of the skin and eyes)
• Dark urine and pale stools
• Nausea and vomiting
• Fever and chills, suggesting infection
• Persistent fatigue, common in PBC

• Medical history and physical examination
• Blood tests: liver function tests, bilirubin levels, and markers like ALP and GGT
• Ultrasound: first-line for gallstones and bile duct obstruction
• MRCP: non-invasive magnetic resonance imaging of the bile ducts
• ERCP: used for both diagnosis and treatment
• Biopsy: may be required for conditions like primary biliary cholangitis

• Gallstones: asymptomatic stones may not require treatment; cholecystectomy is recommended for symptomatic stones
• Cholangitis: treated with antibiotics and bile duct drainage via ERCP
• Biliary strictures: treated with endoscopic stenting or balloon dilation to open the narrowed duct
• Biliary dyskinesia: managed with cholecystectomy if symptoms are severe
• Primary biliary cholangitis: treated with medications like ursodeoxycholic acid (UDCA) to slow disease progression

While not all conditions can be prevented, these steps lower your risk:

• Maintain a healthy weight: obesity increases the risk of gallstones
• Adopt a balanced diet: high in fibre and low in unhealthy fats
• Stay hydrated: proper hydration supports bile production and flow
• Exercise regularly: improves overall metabolism and bile regulation
• Seek prompt treatment: address infections or gallstone symptoms early to avoid complications

• Biliary colic: severe pain from gallstone obstruction
• Acute cholangitis: life-threatening infection of the bile ducts
• Pancreatitis: inflammation of the pancreas due to bile duct obstruction
• Biliary cirrhosis: chronic damage to the liver from prolonged bile duct obstruction or disease

While mild cases may have little impact, severe conditions can disrupt daily life due to:

• Frequent pain episodes
• Dietary restrictions
• Fatigue and reduced energy levels, particularly in autoimmune conditions like PBC

Early diagnosis and treatment significantly improve quality of life and prevent complications.

You should see a specialist if you experience:

• Persistent abdominal pain or discomfort
• Symptoms of jaundice or infection (fever, chills)
• Recurrent episodes of biliary colic
• Diagnosed gallstones with complications like pancreatitis or cholangitis

• Restores bile flow: ensures bile drains from the liver into the intestine
• Prevents complications: avoids long-term infections, bile leaks, strictures and liver damage
• Relieves symptoms: alleviates jaundice, pain and digestive problems caused by the injury

Data insight: studies show that early surgical repair, performed by experienced hepatobiliary surgeons, has success rates of 85% to 95% in restoring normal bile flow and preventing complications.

• Biliary strictures: scar tissue narrows the bile ducts, leading to recurrent jaundice and pain — occurring in 25% to 40% of cases with suboptimal repairs
• Persistent bile leaks: unaddressed leaks can cause infections, peritonitis or abscesses, and are associated with longer hospitalisation and multiple interventions
• Cholangitis: recurrent infections of the bile ducts, with a mortality rate of up to 10% in untreated cases
• Liver damage or failure: chronic bile obstruction can lead to cirrhosis, with some patients requiring liver transplantation
• Diminished quality of life: chronic pain, fatigue and frequent hospitalisations significantly impair physical and mental health

• Delayed diagnosis: waiting too long to identify and address the injury
• Improper technique: misaligned repairs or failure to recognise the extent of the damage
• Inadequate expertise: general surgeons without specialised hepatobiliary training face higher complication rates
• Lack of follow-up care: missed opportunities to detect and manage complications early

Data insight: centres with low experience in bile duct repairs report failure rates of up to 50%, compared to 5% to 10% in high-volume, specialised centres.

• Precise assessment: advanced imaging like MRCP or ERCP ensures accurate evaluation of the injury
• Tailored surgical techniques: primary repair or stenting may suffice for minor injuries, while techniques like Roux-en-Y hepaticojejunostomy have a high success rate for complex injuries
• Multidisciplinary approach: collaboration with gastroenterologists, interventional radiologists and infectious disease specialists enhances care
• Close monitoring post-surgery: regular follow-ups with imaging and liver function tests detect issues early

Data insight: surgeries performed by experienced hepatobiliary teams achieve long-term success rates of 85% to 95%, compared to 50% or less in non-specialised settings.

• Early repair (within 72 hours): offers the best outcomes by minimising inflammation
• Delayed repair (after 6–8 weeks): allows inflammation to subside but requires careful interim management
• Intermediate repair (during active inflammation): carries the highest risk of failure and complications

Data insight: delayed repairs have a slightly lower success rate (70%–90%) than early repairs (85%–95%), but outcomes depend heavily on surgical expertise.

• Seek specialists: choose surgeons trained in hepatobiliary or gastrointestinal surgery
• Prefer high-volume centres: hospitals with experience in complex bile duct repairs have lower complication rates
• Check success rates: ask about the surgeon's experience and outcomes in bile duct injury repairs

Bile duct cancer forms in the bile ducts, which carry bile from the liver to the small intestine. It can develop in several parts of the system:

• Intrahepatic cholangiocarcinoma: occurs inside the liver
• Extrahepatic cholangiocarcinoma: develops outside the liver, including near the gallbladder or small intestine
• Perihilar cholangiocarcinoma: occurs where the bile ducts enter the liver

This cancer can grow slowly and may not cause symptoms until it is advanced.

While the exact cause remains unclear, several factors may increase the risk:

• Chronic liver diseases such as cirrhosis and hepatitis
• Primary sclerosing cholangitis (PSC): an inflammatory disease of the bile ducts
• Liver fluke infections: more common in Southeast Asia
• Gallstones and other bile duct abnormalities
• Age and gender: most commonly diagnosed in people over 65, with men at higher risk

Some people have multiple risk factors; others develop bile duct cancer without any of these conditions.

Symptoms can be vague and may resemble other conditions. The most common signs include:

• Jaundice: yellowing of the skin or eyes
• Abdominal pain, particularly in the upper right side
• Itchy skin
• Unexplained weight loss
• Dark urine and pale stools
• Fever and chills

Diagnosis often involves multiple steps, starting with a medical history review and physical exam. Key tests include:

• Imaging tests: CT scans, MRIs or MRCP provide detailed pictures of the bile ducts and any tumours
• ERCP: a procedure to visualise the bile ducts and take tissue samples if necessary
• Blood tests: check liver function and tumour markers that may indicate cancer
• Biopsy: a tissue sample taken during ERCP or surgery to confirm the diagnosis

Early detection is critical, as bile duct cancer is often diagnosed in later stages, which can limit treatment options.

Treatment varies based on the tumour's location, size and stage:

• Surgery: the most effective treatment, mainly if the cancer is confined to a specific area. Resection removes part of the bile duct, liver or gallbladder to eliminate the tumour. A liver transplant may be recommended in a very select group of patients
• Endoscopic procedures: for those who cannot undergo surgery, stenting may relieve bile duct blockages and ease symptoms such as jaundice
• Chemotherapy and radiation: often used when surgery is not an option — chemotherapy may shrink tumours, while radiation helps manage pain and control growth
• Targeted therapy and immunotherapy: newer therapies for advanced stages or specific genetic mutations

The prognosis depends mainly on how early the cancer is detected. The five-year survival rate is higher for patients diagnosed earlier, where surgery is more likely to be successful. However, bile duct cancer is often diagnosed in its later stages, which can make treatment more challenging.

Early-stage cancers that can be surgically removed have the best chance for long-term survival. For more advanced cases, treatment can help manage symptoms and improve quality of life. Because the disease is rare, ongoing research and clinical trials are essential to developing new, more effective treatments.

Surgery is the primary treatment if the tumour is localised and can be entirely removed. The type depends on the cancer's location — resection removes the tumour and a portion of surrounding tissue, including parts of the bile duct or liver.

Surgery can be curative for patients diagnosed in the early stages. However, if the cancer has spread too far, palliative treatments may be considered to improve symptoms and quality of life.

• Emotional support: be a compassionate listener and help them navigate treatment options
• Practical help: assist with daily tasks, such as transport to appointments or managing household chores
• Stay informed: learn about the disease, treatment options and potential side effects to help make informed decisions together
• Seek support: encourage your loved one to connect with support groups or speak with a counsellor to help manage the emotional impact of the diagnosis